Related references
Note: Only part of the references are listed.Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia
Valentino D'Onofrio et al.
INFECTION GENETICS AND EVOLUTION (2020)
The first nationwide multicenter study ofAcinetobacter baumanniirecovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates
Bojana Lukovic et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)
BacPipe: A Rapid, User-Friendly Whole-Genome Sequencing Pipeline for Clinical Diagnostic Bacteriology
Basil B. Xavier et al.
ISCIENCE (2020)
Draft genome sequence of an OXA-23, OXA-66, ADC-25 and TEM-1D co-producing Acinetobacter baumannii ST195 isolated from a patient with neonatal pneumonia in China
Weibiao Lv et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network: a COMBACTE LAB-Net survey
T. Kostyanev et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Carbapenem-resistant Acinetobacter baumannii: Current status of the problem in four Bulgarian university hospitals (2014-2016)
Tanya Strateva et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
GrapeTree: visualization of core genomic relationships among 100,000 bacterial pathogens
Zhemin Zhou et al.
GENOME RESEARCH (2018)
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015)
Theodoros Karampatakis et al.
FUTURE MICROBIOLOGY (2017)
Clonal Transmission of Gram-Negative Bacteria with Carbapenemases NDM-1, VIM-1, and OXA-23/72 in a Bulgarian Hospital
Yvonne Pfeifer et al.
MICROBIAL DRUG RESISTANCE (2017)
Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii
Paul G. Higgins et al.
PLOS ONE (2017)
EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study
Belen Gutierrez-Gutierrez et al.
BMJ OPEN (2017)
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance
T. Kostyanev et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia
Laurent Dortet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Novel Aminoglycoside Resistance Transposons and Transposon-Derived Circular Forms Detected in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
Nabil Karah et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
First report of an NDM-1 metallo-β-lactamase-producing Acinetobacter baumannii clinical isolate in Greece
Evangelia Voulgari et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Carbapenem-Resistant Acinetobacter baumannii from Serbia: Revision of CarO Classification
Katarina Novovic et al.
PLOS ONE (2015)
GES-type and OXA-23 carbapenemase-producing Acinetobacter baumannii in Turkey
Arzu Nazli Zeka et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Association of the Emerging Carbapenemase NDM-1 with a Bleomycin Resistance Protein in Enterobacteriaceae and Acinetobacter baumannii
Laurent Dortet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals
R. A. Bonnin et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme
A. Di Popolo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09)
Vasiliki Gogou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Global spread of carbapenem-resistant Acinetobacter baumannii
Paul G. Higgins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Coexistence of bla(OXA-23) with bla(NDM-1) and armA in clinical isolates of Acinetobacter baumannii from India
Kumarasamy Karthikeyan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Characterization of Epidemiologically Unrelated Acinetobacter baumannii Isolates from Four Continents by Use of Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Sequence-Based Typing of blaOXA-51-like Genes
Ahmed Hamouda et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii
B. A. Evans et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Current concepts: Acinetobacter infection
L. Silvia Munoz-Price et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa
Robert A. Bonomo et al.
CLINICAL INFECTIOUS DISEASES (2006)
Share Paper
